Use of Flonase During Pregnancy

Safety Profile and Evidence Base

• A meta-analysis found no increased risk of major malformations, preterm delivery, low birth weight, or pregnancy-induced hypertension with intranasal corticosteroid use during pregnancy, according to the American Academy of Allergy, Asthma, and Immunology 1
• Fluticasone propionate has accumulated substantial safety data alongside budesonide and beclomethasone, making it one of the better-studied intranasal corticosteroids in pregnancy, as reported by the American College of Allergy, Asthma, and Immunology 1

When to Use Fluticasone During Pregnancy

• If you were already using Flonase before pregnancy, the American Academy of Allergy, Asthma, and Immunology recommends continuing your current regimen without interruption, as discontinuing effective therapy unnecessarily can significantly impact quality of life and potentially worsen comorbid conditions like asthma 1
• Budesonide is technically preferred as the first choice when initiating therapy during pregnancy due to its FDA Pregnancy Category B classification based on more extensive human safety data, according to the American College of Obstetricians and Gynecologists 1, 2, 3

Dosing Strategy

• Use the lowest effective dose that adequately controls your symptoms, as recommended by the American Academy of Allergy, Asthma, and Immunology, and avoid exceeding manufacturer-recommended dosing 2, 4

Important Distinctions and Pitfalls

• Oral corticosteroids carry significantly different and more substantial risks, especially during the first trimester, including increased risk of cleft lip/palate, preeclampsia, preterm delivery, low birth weight, and gestational diabetes, as reported by the American College of Obstetricians and Gynecologists 2, 3
• Intranasal corticosteroids have negligible systemic absorption compared to oral formulations, according to the American Academy of Allergy, Asthma, and Immunology 2, 3

Alternative Intranasal Corticosteroids

• Budesonide (Pregnancy Category B) has the most extensive human safety data, as reported by the American College of Allergy, Asthma, and Immunology, and the American College of Obstetricians and Gynecologists 1, 2, 3
• Mometasone (Nasonex) is explicitly listed as safe by expert panels at recommended doses, according to the American Academy of Allergy, Asthma, and Immunology, and the American College of Allergy, Asthma, and Immunology 2, 4

Flonase Safety in Pregnancy

Evidence-Based Recommendations

• The American Academy of Otolaryngology recommends that all modern intranasal corticosteroids, including fluticasone, are considered safe for use during pregnancy at recommended doses, based on expert panel consensus and studies in non-pregnant populations 5, 6
• A study of 53 pregnant women using fluticasone propionate nasal spray showed no detectable influence on maternal cortisol levels, no differences in fetal growth on ultrasound, and no adverse pregnancy outcomes, providing evidence for the safety of fluticasone during pregnancy 5

Risks Associated with Oral Corticosteroids

• The use of oral corticosteroids during pregnancy is associated with an increased risk of cleft lip with or without cleft palate, preeclampsia, preterm delivery, low birth weight infants, and gestational diabetes, highlighting the importance of distinguishing between intranasal and oral corticosteroids 5, 7

Breastfeeding Compatibility

• The American Academy of Pediatrics considers fluticasone compatible with breastfeeding, although it is unknown whether fluticasone is excreted in human breast milk, and caution is advised 5

Flonase Use During Pregnancy

Safety Evidence

• The American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology confirm that intranasal corticosteroids, including fluticasone, are safe during pregnancy at recommended doses 8, 9, 10, 11
• A meta-analysis demonstrated no increased risk of major malformations, preterm delivery, low birth weight, or pregnancy-induced hypertension with intranasal corticosteroid use during pregnancy 9, 10
• The American College of Allergy, Asthma, and Immunology states there is no substantial difference in efficacy and safety among available intranasal corticosteroids (fluticasone, budesonide, mometasone) 8, 9, 10

Clinical Decision Algorithm

• The American College of Allergy, Asthma, and Immunology recommends continuing fluticasone propionate nasal spray without interruption if already using it before pregnancy, as discontinuing effective therapy can significantly impact quality of life and potentially worsen comorbid conditions like asthma 8, 9, 10
• If starting therapy during pregnancy, intranasal budesonide is technically preferred as first-line therapy due to its FDA Pregnancy Category B classification based on more extensive human safety data 8, 9, 10

Dosing Strategy

• The American College of Allergy, Asthma, and Immunology recommends using the lowest effective dose that adequately controls symptoms 8, 9, 10

Alternative Intranasal Corticosteroids

• Budesonide (Rhinocort) has the most extensive human safety data, with a Pregnancy Category B classification 8, 9, 10
• Mometasone (Nasonex) is explicitly listed as safe by expert panels at recommended doses 11
• Beclomethasone has demonstrated no convincing evidence of congenital defects 8, 9, 10

What NOT to Use

• The American Academy of Allergy, Asthma, and Immunology recommends avoiding oral decongestants (pseudoephedrine, phenylephrine) during the first trimester, as they have been associated with increased congenital malformations 10
• First-generation antihistamines should be avoided due to their sedative and anticholinergic properties 11

Guideline Summary: Use of Fluticasone and Other Intranasal Corticosteroids During Pregnancy

Safety Evidence for Intranasal Corticosteroids

• A meta‑analysis of studies involving pregnant women using intranasal corticosteroids found no increased risk of major congenital malformations, preterm delivery, low birth weight, or pregnancy‑induced hypertension【12】【13】 (high‑quality evidence).
• Fluticasone propionate has accumulated extensive safety data alongside budesonide and beclomethasone, making it one of the best‑studied intranasal corticosteroids in pregnancy【12】【13】【14】.
• In a controlled cohort of 53 pregnant women treated with fluticasone propionate nasal spray, maternal cortisol levels, fetal growth on ultrasound, and pregnancy outcomes were comparable to untreated controls【15】 (moderate evidence).
• Pharmacologic investigations demonstrate that systemic exposure after intranasal administration is markedly lower than after oral corticosteroids, supporting a favorable safety profile【14】 (low‑level evidence).

Clinical Decision: Continuation vs. Initiation

Continuation of Pre‑Pregnancy Therapy

• Women already using fluticasone should continue the same regimen without interruption, using the lowest effective dose【12】【13】【14】.
• No meaningful differences in efficacy or safety have been identified among the various intranasal corticosteroids, so switching agents is unnecessary【12】【13】【14】.

Initiation During Pregnancy

• Intranasal budesonide is preferred as first‑line therapy because it holds FDA Pregnancy Category B based on the most extensive human safety data【12】【13】【15】【14】.
• Fluticasone propionate, mometasone, and fluticasone furoate are also considered safe at recommended doses【15】.

Dosing Recommendations

• Employ the lowest effective dose that controls symptoms, tapering as needed; this principle applies throughout all trimesters【12】【13】【14】.
• Do not exceed the manufacturer‑specified maximum daily dose【12】.

Comparison: Intranasal vs. Oral Corticosteroids

• Intranasal (and inhaled) corticosteroids have negligible systemic absorption and are regarded as safe during pregnancy【14】.
• Oral corticosteroids, especially in the first trimester, are linked to an increased risk of cleft lip with or without cleft palate【15】 (moderate evidence).
• Oral corticosteroids may be justified after the first trimester for severe disease when the benefits of controlling the underlying condition outweigh medication risks【15】【16】.

FDA Pregnancy Category Context

• Fluticasone propionate is classified as Category C (animal studies show adverse effects; human data are insufficient)【12】【13】, yet observational human studies have not demonstrated a gestational risk【12】【13】【14】.
• Budesonide holds Category B status due to the breadth of human safety data, not because it is intrinsically safer than other agents【12】【13】【15】【14】.

Alternative Intranasal Corticosteroids

Medications to Avoid in Pregnancy

• Oral decongestants (e.g., pseudoephedrine, phenylephrine) should be avoided in the first trimester because of an association with increased congenital malformations such as gastroschisis【16】.

Asthma Management in Pregnancy

• Pharmacologic treatment of asthma during pregnancy is safer than allowing uncontrolled symptoms, which can cause fetal hypoxia【16】.
• Budesonide is the preferred inhaled corticosteroid for asthma in pregnancy, but other inhaled corticosteroids—including fluticasone—may be continued if asthma was well‑controlled before conception【16】.

Breastfeeding Considerations

• The American Academy of Pediatrics states that oral steroids are compatible with breastfeeding【15】; while data on fluticasone excretion in breast milk are limited, systemic absorption from intranasal use is minimal, and the benefits of therapy generally outweigh theoretical risks.